NonInvasive Cortical Bone...
Financiado
A Health Technology Assessment of a breakthrough technology in the early diagnos...
A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis and other bone related diseases.
Osteoporosis accounts for more days in the hospital than breast cancer, heart attack, and diabetes, leading to huge healthcare costs. Despite this, bone mineral density (BMD), the current gold standard for diagnosis of osteoporosi...
Osteoporosis accounts for more days in the hospital than breast cancer, heart attack, and diabetes, leading to huge healthcare costs. Despite this, bone mineral density (BMD), the current gold standard for diagnosis of osteoporosis is insufficient, and fails to detect 80% of people at risk of a fragility fracture.
The Porous solution aims to replace BMD as the standard for osteoporosis diagnosis. Using mobile and harmless quantitative ultrasound technology with our patented intelligent algorithms, we can for the first time measure the cortical bone quality down to the microscopic pore level. This gives a multifactorial analysis of fracture risk that overcomes the weaknesses of BMD.
Due to the use of mobile ultrasound systems, this solution can be used anywhere in or outside the hospital, such as primary care facilities. It creates the ability to use the technology for prevention via screening, and opens unprecedented possibilities for the early diagnosis of osteoporosis.
ver más
Duración del proyecto: 27 meses
Fecha Inicio: 2023-01-13
Fecha Fin: 2025-04-30
Fecha Fin: 2025-04-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-01-13
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2022-ACCELERATOROPEN-01:
EIC Accelerator Open
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
4M€
Líder del proyecto
POROUS GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
